June 2013 Vol 4, No 3
Continuing with our series of various unbranded offerings provided by pharmaceuticals and other companies that provide diagnostics and treatments for cancer patients, this list below comes from Merck.
Christopher Louis, MHA, PhD(c), Jonathan Clark, MS, PhD, Katelyn Holmes, BS, Betsy Aumiller, MEd, DEd, Eugene J. Lengerich, VMD, MS
Coordinating care; overcoming patient, provider, and health system barriers; and reducing delays across the care continuum have been long-standing challenges for healthcare managers.
Eugene J. Lengerich, VMD, MS, Betsy Aumiller, MEd, DEd, Brenda C. Kluhsman, PhD, MSS, Marcyann Bencivenga, BA, Christopher Louis, MHA, PhD(c), Linda Fleisher, PhD, MPH, E. D. Paskett, PhD, MSHP, Mark B. Dignan, PhD, MPH
Encompassing 420 counties in 13 states from southern New York to northern Mississippi, Appalachia is largely rural with a population characterized by a high poverty rate, a low educational level, a high rate of uninsurance or underinsurance, and limited access to healthcare. All pose substantial barriers to cancer screening, diagnosis, and treatment and are associated with increased cancer mortality.
Results 1 - 4 of 4